CN203324198U - Body fluid sulfhydryl detection reagent kit - Google Patents
Body fluid sulfhydryl detection reagent kit Download PDFInfo
- Publication number
- CN203324198U CN203324198U CN2013203892410U CN201320389241U CN203324198U CN 203324198 U CN203324198 U CN 203324198U CN 2013203892410 U CN2013203892410 U CN 2013203892410U CN 201320389241 U CN201320389241 U CN 201320389241U CN 203324198 U CN203324198 U CN 203324198U
- Authority
- CN
- China
- Prior art keywords
- test paper
- body fluid
- hypomere
- epimere
- groove
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a body fluid sulfhydryl detection reagent kit. The body fluid sulfhydryl detection reagent kit comprises a panel and a base plate, and further comprises a piece of first composite test paper and a piece of second composite test paper. A first groove of the first composite test paper and a second groove of the second composite test paper are respectively formed in the base plate. A first sample adding hole and a first color development hole which correspond to the first groove are formed in the panel. A second sample adding hole and a second color development hole which correspond to the second groove are formed in the panel. According to the body fluid sulfhydryl detection reagent kit, all reagent components are composited in the body fluid sulfhydryl detection process, unstable chemical reagents are separated to obtain relative reagents through mummification stability and the mechanical structural design, the stability of the reagents is greatly improved at the normal temperature, any auxiliary reagents and equipment are not required in the checking process, and the result can be observed in 10 minutes only after a drop of a body fluid sample is dropped in the first sample adding hole and a drop of the body fluid sample is dropped in the second sample adding hole. The body fluid sulfhydryl detection reagent kit is high in speed, easy to operate and capable of rapidly conducting the large-scale crowd screening work.
Description
Technical field
The utility model belongs to rapid in-vitro diagnostic kit field, is specifically related to a kind of body fluid sulfydryl detection kit.
Background technology
The cervical cancer pathogenesis rate occupies first of women's cancer, at present, the method of the diagnosis and detection for cervix cancer in clinical practice has: the inspection of cervix Scrape method, iodine test, uterine neck and cervical canal biopsy, vaginoscopy, conization, TCT detect, high-risk HPV detects etc., but it is the shortcomings such as testing process professional technique conditional request complicated, that detect is high, the time is long, expense is high that these detection methods and technology all exist, can only detect and use in specialist hospital, be difficult to extensively promote in the crowd and use." the portable long-acting quick body fluid detection of SH kit " of the people such as Lin Genchun invention is although be quick, an easy method, but kit still exists and forms the deficiencies such as structure is more complicated, operation steps is many, and the reagent holding time in the mentioned reagent box is short, poor stability.
The utility model content
The purpose of this utility model is to overcome the prior art defect, and a kind of body fluid sulfydryl detection kit is provided.
The technical solution of the utility model is as follows:
A kind of body fluid sulfydryl detection kit, comprise panel and base plate, also comprise one first compound test paper and one second compound test paper, base plate is provided with the first groove and the second groove of installing respectively the first compound test paper and the second compound test paper, on described panel, corresponding the first groove offers the first well and the first colour developing hole, and corresponding the second groove is provided with the second well and the second colour developing hole.
In a preferred embodiment of the present utility model, the described first compound test paper comprises one first connected epimere test paper and one first hypomere test paper, described the first epimere test paper is made after soaking the first damping fluid drying, described the first hypomere test paper is made after soaking phosphotungstic acid and the second damping fluid drying, described the first well below is the first epimere test paper, and described the first below, colour developing hole is the first hypomere test paper.
In a preferred embodiment of the present utility model, the described second compound test paper paper bag is drawn together one second connected epimere test paper and one second hypomere test paper, described the second epimere test paper is made after soaking the first damping fluid and mercuric chloride drying, described the second hypomere test paper is made after soaking phosphotungstic acid, mercuric chloride and the second damping fluid drying, described the second well below is the second epimere test paper, and described the second below, colour developing hole is the second hypomere test paper.
In a preferred embodiment of the present utility model, form kit together with described panel is installed in by bonding or buckle up and down with base plate, or described panel side embeds base plate generate a reagent box.
In a preferred embodiment of the present utility model, between described the first epimere test paper and the first hypomere test paper, also establish a compartmented; Yet establish a compartmented between described the second epimere paper and described the second hypomere paper.
The beneficial effects of the utility model are:
1, the utility model is compounded with all reagent compositions of body fluid sulfydryl testing process, unsettled chemical reagent is stablized to the first damping fluid and the phosphotungstic acid that divides defection to react to each other with Design of Mechanical Structure by mummification, reagent stability is at normal temperatures improved greatly, checking process is without any auxiliary reagent and equipment, only need to splash into respectively a body fluid sample at the first well and the second well, after 10 minutes, observations gets final product, speed is fast, simple to operate, can carry out fast large-scale Mass screening work;
2, of the present utility model simple in structure, with low cost, be applicable to suitability for industrialized production.
The accompanying drawing explanation
The structural representation that Fig. 1 is panel of the present utility model
The structural representation that Fig. 2 is base plate of the present utility model;
The front elevation that Fig. 3 is the first compound test paper of the present utility model;
Fig. 4 is the cut-open view of Fig. 3 along the A-A line;
The front elevation that Fig. 5 is the second compound test paper of the present utility model;
Fig. 6 is the cut-open view of Fig. 5 along the B-B line.
Embodiment
Below by embodiment in connection with accompanying drawing, the technical solution of the utility model is further detailed and describes.
As depicted in figs. 1 and 2, a kind of body fluid sulfydryl detection kit, a panel 3 and a base plate 4 together with comprising one first compound test paper 1, one second compound test paper 2 and being installed in up and down by buckle, base plate 4 is provided with the first groove 43 and the second groove 44 of installing respectively the first compound test paper 1 and the second compound test paper 2, on described panel 3, corresponding the first groove 43 offers the first well 31 and the first colour developing hole 41, and corresponding the second groove 44 is provided with the second well 32 and the second colour developing hole 42; Described panel forms kit together with being installed in up and down by bonding or buckle with base plate, or described panel side embeds base plate generate a reagent box.
As shown in Figure 3 and Figure 4, the described first compound test paper 1 comprises the hard sheet 13 of one first paper, the hard sheet 13 of this first paper is provided with the first hypomere test paper 12 that soaks dry the first epimere test paper 11 formed and form with phosphotungstic acid, the second damping fluid immersion drying with the first damping fluid partly overlapped together, preferably between the first epimere test paper and the first hypomere test paper, also establishes a compartmented; Described the first well 31 belows are the first epimere test paper 11, and described the first colour developing 41 belows, hole are the first hypomere test paper 12.
As shown in Figure 5 and Figure 6, the described second compound test paper 2 comprises the hard sheet 23 of one second paper, the hard sheet 23 of this second paper is provided with the second hypomere test paper 23 that soaks dry the second epimere test paper 21 formed and form with phosphotungstic acid, the second damping fluid and mercuric chloride immersion drying with the first damping fluid, mercuric chloride partly overlapped together, preferably between the second epimere test paper and the second hypomere test paper, also establishes a compartmented; Described the second well 32 belows are the second epimere test paper 21, and described the second colour developing 42 belows, hole are the second hypomere test paper 22.
Using method of the present utility model is as follows:
Splash into respectively women's body fluid sample to be detected at the first well 31 and the second well 32, observe the blueness reaction in the first colour developing hole 41 and the second colour developing hole 42 after 10 minutes, when the blue depth in the first colour developing hole 41 and the second colour developing hole 42 when consistent, negative result, show not have evidence explanation detected person to suffer from cervix cancer or body precancerous lesion (CIN) occur; When the blueness in the first colour developing hole 41 is darker than the blueness in the second colour developing hole 42, positive result, show that the detected person may suffer from generation precancerous lesion (CIN) or the rear disease relapse for the treatment of in cervix cancer, body, can advise that the detected person receives further inspection to make a definite diagnosis.
The above, it is only preferred embodiment of the present utility model, therefore can not limit according to this scope that the utility model is implemented, the equivalence of doing according to the utility model the scope of the claims and description changes and modifies, and all should still belong in the scope that the utility model contains.
Claims (5)
1. a body fluid sulfydryl detection kit, comprise panel and base plate, it is characterized in that: also comprise one first compound test paper and one second compound test paper, base plate is provided with the first groove and the second groove of installing respectively the first compound test paper and the second compound test paper, on described panel, corresponding the first groove offers the first well and the first colour developing hole, and corresponding the second groove is provided with the second well and the second colour developing hole.
2. a kind of body fluid sulfydryl detection kit as claimed in claim 1, it is characterized in that: the described first compound test paper comprises one first connected epimere test paper and one first hypomere test paper, described the first epimere test paper is made after soaking the first damping fluid drying, described the first hypomere test paper is made after soaking phosphotungstic acid and the second damping fluid drying, described the first well below is the first epimere test paper, and described the first below, colour developing hole is the first hypomere test paper.
3. a kind of body fluid sulfydryl detection kit as claimed in claim 2, it is characterized in that: the described second compound test paper comprises one second connected epimere test paper and one second hypomere test paper, described the second epimere test paper is made after soaking the first damping fluid and mercuric chloride drying, described the second hypomere test paper is made after soaking phosphotungstic acid, mercuric chloride and the second damping fluid drying, described the second well below is the second epimere test paper, and described the second below, colour developing hole is the second hypomere test paper.
4. a kind of body fluid sulfydryl detection kit as described as arbitrary claim in claims 1 to 3, it is characterized in that: form kit together with described panel is installed in by bonding or buckle up and down with base plate, or described panel side embeds base plate generate a reagent box.
5. a kind of body fluid sulfydryl detection kit as claimed in claim 2 or claim 3, is characterized in that: between described the first epimere test paper and the first hypomere test paper, also establish a compartmented; Yet establish a compartmented between described the second epimere paper and described the second hypomere paper.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013203892410U CN203324198U (en) | 2013-07-02 | 2013-07-02 | Body fluid sulfhydryl detection reagent kit |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013203892410U CN203324198U (en) | 2013-07-02 | 2013-07-02 | Body fluid sulfhydryl detection reagent kit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203324198U true CN203324198U (en) | 2013-12-04 |
Family
ID=49663537
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013203892410U Expired - Lifetime CN203324198U (en) | 2013-07-02 | 2013-07-02 | Body fluid sulfhydryl detection reagent kit |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203324198U (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114184693A (en) * | 2021-10-14 | 2022-03-15 | 重庆医科大学 | Application of 4-hydroxyphenylacetic acid as marker in preparation of diagnostic kit for sepsis encephalopathy |
-
2013
- 2013-07-02 CN CN2013203892410U patent/CN203324198U/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114184693A (en) * | 2021-10-14 | 2022-03-15 | 重庆医科大学 | Application of 4-hydroxyphenylacetic acid as marker in preparation of diagnostic kit for sepsis encephalopathy |
| CN114184693B (en) * | 2021-10-14 | 2023-10-13 | 重庆医科大学 | Application of 4-hydroxyphenylacetic acid as marker in preparation of diagnosis kit for sepsis encephalopathy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wright Jr et al. | Alternative approaches to cervical cancer screening for developing countries | |
| CN103424402A (en) | Body fluid sulfydryl detection kit | |
| Kavatkar et al. | Study of a manual method of liquid-based cervical cytology | |
| Mehrotra | The role of cytology in oral lesions: a review of recent improvements | |
| CN203324197U (en) | Body fluid sulfhydryl detection reagent kit | |
| WO2008081451A3 (en) | Methods and kits for analyzing genetic material of a fetus | |
| JPWO2013146843A1 (en) | Medical image processing apparatus and program | |
| EP2566983A4 (en) | Serial analysis of biomarkers for disease diagnosis | |
| CN107250346A (en) | Cell-preservation liquid and its utilization and the manufacture method of cell-preservation liquid | |
| CN104483472B (en) | A kind of diagnostic reagent for cervical carcinogenesis cell detection and preparation method thereof | |
| JP2017502267A5 (en) | ||
| CN203705447U (en) | Urine analysis test strip capable of judging front, rear, positive and reverse directions and control system thereof | |
| Ishigami et al. | Preoperative assessment of the depth of early gastric cancer invasion by transabdominal ultrasound sonography (TUS): a comparison with endoscopic ultrasound sonography (EUS). | |
| CN104237192A (en) | Method for detecting ferric ions through graphene quantum dot probes | |
| Zhang et al. | Electrokinetic gated injection-based microfluidic system for quantitative analysis of hydrogen peroxide in individual HepG2 cells | |
| Bhatla et al. | Evaluation of adjunctive tests for cervical cancer screening in low resource settings | |
| CN203324198U (en) | Body fluid sulfhydryl detection reagent kit | |
| NZ592819A (en) | Thyroid analyte detection and measurement | |
| CN103471903B (en) | The collocation method of section immobile liquid and application thereof | |
| Rouzier | Management of CIN1 | |
| CN104714030B (en) | A kind of cervical cancer urine detection test kit | |
| CN103505217A (en) | Method for accurately measuring size of nidus under endoscope | |
| Melo et al. | Expression of the immunohistochemical markers p16 and Ki-67 and their usefulness in the diagnosis of cervical intraepithelial neoplasms | |
| CN202092960U (en) | Cervical carcinoma fast inspection kit | |
| Aruhuri et al. | Prevalence of cervical human papillomavirus (HPV) infection in Vanuatu |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20131204 |